Medical News

RSS

Type 2 diabetes may be derived from composition of specific intestinal flora

Whether you have an increased risk of developing type 2 diabetes, in the future may be derived from the composition of your intestinal flora. That according to new metagenomics research of an international consortium of scientists, including Jeroen Raes, connected to VIB and Vrije Universiteit Brussel. Metagenomics is the study of the genetic material of complete ecosystems, in this case the human intestine. This study appears in the leading journal Nature.

27 Sep 2012

Can rebate checks really change public perception about the health law?

National Journal reports that although the checks are one of the earliest, tangible benefits for people with insurance, they are unlikely to alter the public view -- in part because they have gone to only about 10 percent of households.

27 Sep 2012

DNp63a protein employs epigenetics to keep cancer cells alive

Squamous cell carcinoma (SCC) is diagnosed in about 700,000 people in the United States every year. Commonly contributing to SCC is a protein called DNp63a - it goes abnormally high and the ability of a patient's body to kill cancer cells goes abnormally low. In many cases of SCC, it's just that simple. And science thought the function of DNp63a was simple, as well: the tumor suppressor gene p53 is responsible for recognizing and killing cancer cells, and in SCC, it's usually inactivated. It looked like high DNp63a repressed p53, made SCC.

27 Sep 2012

Hospitals respond to feds' warning about electronic records, billing fraud

Hospital industry groups responded Tuesday to the warning issued by Health and Human Services Secretary Kathleen Sebelius and Attorney General Eric Holder, saying that the federal government shares part of the blame, because it hasn't provided hospitals adequate guidance on billing for common services.

27 Sep 2012

Amakem commences AMA0076 Phase 2a study in glaucoma and ocular hypertension

Amakem NV, a kinase platform company focusing on ophthalmology, today announces that it has initiated a Phase 2a proof of concept study of its novel Rho Kinase (ROCK) inhibitor, AMA0076, in patients with glaucoma and ocular hypertension.

27 Sep 2012

Meeting needs of children living with, affected by HIV 'central' to PEPFAR mission

"Meeting the needs of children, including both children living with HIV and those affected by the disease in other ways, is not peripheral to PEPFAR's mission -- it is central," U.S. Global AIDS Coordinator Ambassador Eric Goosby writes in USAID's "DipNote" blog, adding, "It's a responsibility, and an opportunity as part of our push toward an AIDS-free generation."

27 Sep 2012

Hatch seeks more details from the Obama administration about federal exchanges

Sen. Orrin Hatch, R- Utah, charged that states can't make decisions about whether to pursue their own health insurance exchanges or to rely on the federal fallback version unless they have more information.

27 Sep 2012

NYU Langone creates new groundbreaking collaboration in autism research

NYU Langone Medical Center announced today the creation of a new groundbreaking collaboration in autism research. The Autism Brain Imaging Data Exchange (ABIDE) is a database of brain scans from more than 15 leading international research institutions and academic medical centers.

27 Sep 2012

Commitment to good investments, ability to say 'no' at heart of foreign aid reform

"During these tough budget times, citizens across the world rightfully question the effectiveness of government spending, including funds spent on foreign assistance," Daniel Yohannes, chief executive officer of the Millennium Challenge Corporation (MCC), writes in this Foreign Policy opinion piece.

27 Sep 2012

Forest submits levomilnacipran NDA with FDA for treatment of major depressive disorder

Forest Laboratories, Inc. and Pierre Fabre Laboratories todayannounced that Forest has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for levomilnacipran, a serotonin norepinephrine reuptake inhibitor (SNRI) for the treatment of Major Depressive Disorder (MDD) in adults.

27 Sep 2012

Viewpoints: 'Redistribution' debate; Reducing delayed, missed and incorrect diagnoses

The Affordable Care Act, which levies new taxes on the wealthy to expand access to health care for the near poor, seems on track to become the biggest increase in government redistribution since the Johnson administration.

27 Sep 2012

Dr. Reddy's introduces generic Singulair oral granules in the U.S.

Dr. Reddy's Laboratories announced today that it has launched Montelukast Sodium Oral Granules, a bioequivalent generic version of Singulair (montelukast sodium) oral granules in the US market on September, 26, 2012, following the approval by the United States Food & Drug Administration (USFDA) of Dr.Reddy's ANDA for Montelukast Sodium Oral Granules.

27 Sep 2012

WHO urges health workers to be alert for patients exhibiting symptoms of new SARS-like virus

"The World Health Organization on Wednesday urged health workers around the world to report any patient with acute respiratory infection who may have traveled to Saudi Arabia or Qatar and been exposed to a new SARS-like virus confirmed in two people so far," Reuters reports.

27 Sep 2012

Scientists discover 12 genetic markers for ED in prostate cancer patients after radiotherapy

In the first study of its kind, a research team led by Mount Sinai School of Medicine and Albert Einstein College of Medicine of Yeshiva University discovered 12 genetic markers associated with the development of erectile dysfunction (ED) in prostate cancer patients who were treated with radiation.

27 Sep 2012

Weekly campaign highlights: News from Pennsylvania, Florida, Ohio and North Carolina

As election day approaches, Kaiser Health News' Sarah Barr samples news coverage each week from swing states around the country – how health policy developments, and other political issues, are playing in this year's vote.

27 Sep 2012

MicroRNA processing in fat tissue plays a major role in aging and stress resistance

As part of their ongoing research investigating the biology of aging, the greatest risk factor for type 2 diabetes and other serious diseases, scientists at Joslin Diabetes Center have identified a new factor - microRNA processing in fat tissue - which plays a major role in aging and stress resistance.

27 Sep 2012

Coca Cola, Global Fund announce expansion of project to deliver medicines in rural areas

The Coca-Cola Company and the Global Fund to Fight AIDS, Tuberculosis and Malaria have announced the expansion of a pilot project, called "Project Last Mile," that uses Coca Cola's "'expansive global distribution system and core business expertise' to help deliver critical medicines to remote parts of the world, beginning in rural Africa," Pharma Times reports.

27 Sep 2012

KSU creates simple blood test that can accurately detect lung and breast cancer’s early stages

Researchers at Kansas State University have developed a simple blood test that can accurately detect the beginning stages of cancer.

27 Sep 2012

Texas congressional candidates will face off in Spanish debate, health policies among key issues

Texas' first congressional candidate debate in Spanish could help decide one of the closest races in the country. Incumbent Republican Rep. Francisco "Quico" Canseco, 63, a tea party conservative, will face challenger Pete Gallego, 50, a Democratic state representative, Tuesday night in an hourlong debate aired by Spanish-language network Univision.

27 Sep 2012

Pfizer, Bristol-Myers Squibb report FDA acknowledgement of ELIQUIS NDA resubmission

Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the New Drug Application (NDA) resubmission for ELIQUIS (apixaban) to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (NVAF).

27 Sep 2012

Medical News

Type 2 diabetes may be derived from composition of specific intestinal flora

Can rebate checks really change public perception about the health law?

DNp63a protein employs epigenetics to keep cancer cells alive

Hospitals respond to feds' warning about electronic records, billing fraud

Amakem commences AMA0076 Phase 2a study in glaucoma and ocular hypertension

Meeting needs of children living with, affected by HIV 'central' to PEPFAR mission

Hatch seeks more details from the Obama administration about federal exchanges

NYU Langone creates new groundbreaking collaboration in autism research

Commitment to good investments, ability to say 'no' at heart of foreign aid reform

Forest submits levomilnacipran NDA with FDA for treatment of major depressive disorder

Viewpoints: 'Redistribution' debate; Reducing delayed, missed and incorrect diagnoses

Dr. Reddy's introduces generic Singulair oral granules in the U.S.

WHO urges health workers to be alert for patients exhibiting symptoms of new SARS-like virus

Scientists discover 12 genetic markers for ED in prostate cancer patients after radiotherapy

Weekly campaign highlights: News from Pennsylvania, Florida, Ohio and North Carolina

MicroRNA processing in fat tissue plays a major role in aging and stress resistance

Coca Cola, Global Fund announce expansion of project to deliver medicines in rural areas

KSU creates simple blood test that can accurately detect lung and breast cancer’s early stages

Texas congressional candidates will face off in Spanish debate, health policies among key issues

Pfizer, Bristol-Myers Squibb report FDA acknowledgement of ELIQUIS NDA resubmission

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Latest News